Bio-foods backlash

Article Abstract:

The US biotechnology industry has traditionally been viewed by its European counterpart as an influential bastion of sanity and reason in the public furor about the safety of genetically modified (GM) crops and food products. However, many European bitechnology firms are horrified by signs which strongly suggest that the biotech backlash in Europe has spread to the US. US biotech firms are confronting protests by environmental and consumer groups, closer scrutiny by Congress regarding GM ingredients in food, uncertainty by farmers worried about their ability to sell GM crops, finicky customers, wary retailers and Wall Street investor uncertainty.

---

Wariness squashes pioneering tomato

Article Abstract:

AstraZeneca has withdrawn a genetically modified tomato that it developed from the market and no longer grows or processes the fruit. The decision was prompted by the backlash in Europe against genetic modification. The company grew its first genetically modified tomato crops near Fresno, CA, and banked on permission by authorities to eventually grow them in Italy and Spain. It has yet to receive authorization from European regulators. However, the company believes that it is ideally positioned to prosper from gene manipulating technology as everything in its research pipeline is six or seven years away from reaching consumers.

Product discontinued, AstraZeneca

---

Biotech firm will help Third World harvest rice

Article Abstract:

Zeneca plans to introduce vitamin A-fortified rice in the developing world without charging its normal royalties by 2003. The so-called golden rice is rich in vitamin A, the lack of which causes the deaths of 2 million children under the age of five in the poor nations. The move is in response to criticisms that multionational biotech companies such as Zeneca will be able to control the own and control the food supply in the Third World.

Similar abstracts:

• Abstracts: Websites help users comparison shopping for telecom services. Cellphone makers to display radiation levels
• Abstracts: Luby's proxy fight illustrates investors' readiness to act. The battle for a piece of Eskimo Pie. Shareholder wants to oust Tyson Foods' board
• Abstracts: Viewers sent to the Net for endings of Nike ads. Marion Jones puts new face on Nike ad. Protests let air out of Nike ads
• Abstracts: China trade bill clears House with ease. Ads could derail patients' rights bill. The feel-good elections
• Abstracts: Stores pop up to help seniors buy Canadian drugs. Workers may pay more for care. Health-care rivals agree: uninsured need help

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.